Sideroblastic anemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Sideroblastic anemia}}
=== Incidence ===
* [[Incidence]] of sideroblastic anemia is approximately [number range] per 100,000 individuals worldwide.
* In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
=== Prevalence ===
* The [[prevalence]] of sideroblastic anemia is approximately 800 per 100,000 individuals worldwide.
* In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
* The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
=== Case-fatality rate/Mortality rate ===
* In [year], the [[incidence]] of [disease name] is approximately [number range] per 100,000 individuals with a [[mortality rate]] of [number range]%.
* The case-fatality rate/mortality rate of [disease name] is approximately [number range].
=== Age ===
=== Age ===
* Patients of all age groups may develop sideroblastic anemia.
* Patients of all age groups may develop sideroblastic anemia.
Line 30: Line 15:


=== Region ===
=== Region ===
* The majority of [disease name] cases are reported in [geographical region].
* Sideroblastic anemia is more prevalent in European countries,in peadiatric population.
 
* [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
=== Developed Countries ===
 
=== Developing Countries ===


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 19:47, 7 August 2018

Age

  • Patients of all age groups may develop sideroblastic anemia.
  • Congenital X-linked sideroblastic anemia due to ALAS mutation can remain undiagnosed and then present late in the fourth to eighth decades of life.
  • The incidence of acquired sideroblastic anemia increases with age; the median age at diagnosis is 74 years.
  • Chronic sideroblastic anemia is usually first diagnosed among middle and older age group.[1]

Race

  • There is no racial predilection to sideroblastic anemia.

Gender

  • Males are more commonly affected than females in X-linked recessive types of sideroblastic anemia.
  • A female would have to inherit 1 abnormal chromosome from each parent to acquire the sideroblastic anemia.
  • Primary acquired sideroblastic anemia was found in 60.4% male and 39.6% female.[1]

Region

  • Sideroblastic anemia is more prevalent in European countries,in peadiatric population.

Epidemiology and Demographics

Hereditary sideroblastic anemia, being sex-linked, primarily affects males.

• Primary acquired sideroblastic anemia is usually a disease of the elderly.In 25 bone marrow biopsies of children younger than 13 years from Atlanta, Georgia (United States), with anemia, the prevalence of ringed sideroblasts was 8%. [50]

In France, the prevalence of ringed sideroblasts was 57% in patients with primary MDS. [51] In the United Kingdom, amongst healthy volunteers undergoing bone marrow biopsy, siderotic granules (not ring sideroblasts) were present in 29% of men and 19% of women. [52]

Although usually manifested in childhood, congenital X-linked sideroblastic anemia due to ALAS mutation can remain undiagnosed and then present late in the fourth to eighth decades of life. [53, 54] The median age of occurrence of primary acquired sideroblastic anemia is 74 years. [55]

X-linked recessive types of sideroblastic anemia occur more commonly in males. A female would have to inherit 1 abnormal chromosome from each parent to acquire the disease. Progesterone and pregnancy have been reported to induce relapse of sideroblastic anemia. [

References

  1. 1.0 1.1 Hadnagy C (1991). "Primary acquired sideroblastic anemia and myelodysplastic syndrome from a geriatric point of view". Z Gerontol. 24 (2): 105–9. PMID 1877285.

Template:WH Template:WS